1. Home
  2. HOWL vs RGS Comparison

HOWL vs RGS Comparison

Compare HOWL & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • RGS
  • Stock Information
  • Founded
  • HOWL 2017
  • RGS 1922
  • Country
  • HOWL United States
  • RGS United States
  • Employees
  • HOWL N/A
  • RGS N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • RGS Other Consumer Services
  • Sector
  • HOWL Health Care
  • RGS Consumer Discretionary
  • Exchange
  • HOWL Nasdaq
  • RGS Nasdaq
  • Market Cap
  • HOWL 64.5M
  • RGS 70.8M
  • IPO Year
  • HOWL 2021
  • RGS 1991
  • Fundamental
  • Price
  • HOWL $1.56
  • RGS $30.10
  • Analyst Decision
  • HOWL Strong Buy
  • RGS
  • Analyst Count
  • HOWL 5
  • RGS 0
  • Target Price
  • HOWL $7.20
  • RGS N/A
  • AVG Volume (30 Days)
  • HOWL 1.3M
  • RGS 12.0K
  • Earning Date
  • HOWL 11-14-2025
  • RGS 11-12-2025
  • Dividend Yield
  • HOWL N/A
  • RGS N/A
  • EPS Growth
  • HOWL N/A
  • RGS 20.23
  • EPS
  • HOWL N/A
  • RGS 46.10
  • Revenue
  • HOWL N/A
  • RGS $210,134,000.00
  • Revenue This Year
  • HOWL N/A
  • RGS N/A
  • Revenue Next Year
  • HOWL N/A
  • RGS N/A
  • P/E Ratio
  • HOWL N/A
  • RGS $0.69
  • Revenue Growth
  • HOWL N/A
  • RGS 3.52
  • 52 Week Low
  • HOWL $0.60
  • RGS $15.00
  • 52 Week High
  • HOWL $2.96
  • RGS $31.50
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 45.71
  • RGS 57.59
  • Support Level
  • HOWL $1.55
  • RGS $29.21
  • Resistance Level
  • HOWL $1.83
  • RGS $30.50
  • Average True Range (ATR)
  • HOWL 0.13
  • RGS 0.73
  • MACD
  • HOWL -0.03
  • RGS -0.23
  • Stochastic Oscillator
  • HOWL 14.71
  • RGS 49.28

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: